Catherine Lindon

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Life science alliance

eLife

Open biology

Oncogene

University of Cambridge

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Jun 01 2015

United Kingdom

University Lecturer :: Pharmacology

University of Cambridge Oct 01 2008 - May 31 2015

United Kingdom

Group Leader :: Genetics

University of Cambridge Feb 01 2005 - Jan 31 2009

United Kingdom

Career Development Fellow, Senior Research Associate :: Gurdon Institute

University of Cambridge Feb 01 2002 - Jan 31 2005

United Kingdom

Research Associate :: Gurdon Institute

University of Cambridge Jul 01 2000 - Jan 31 2002

United Kingdom

Wellcome Trust Advanced Training Fellow :: Gurdon Institute

Institut Pasteur Apr 01 1996 - Jun 30 2000

France

Postdoctoral fellow :: Developpement Cellulaire

Education History

University of London Oct 01 1990 - Sep 30 1994

United Kingdom

PHD :: ICRF

Publications

Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Roberta Cacioppo, Hesna Begum Akman, Taner Tuncer, Ayse Elif Erson-Bensan, Catherine Lindon
Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12 (2023)
Italia Anna Asteriti, Federica Polverino, Venturina Stagni, Valentina Sterbini, Camilla Ascanelli, Francesco Davide Naso, Anna Mastrangelo, Alessandro Rosa, Alessandro Paiardini, Catherine Lindon, Giulia Guarguaglini
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life science alliance 6 (5) (2023)
Ahmed Abdelbaki, Camilla Ascanelli, Cynthia N Okoye, H Begum Akman, Giacomo Janson, Mingwei Min, Chiara Marcozzi, Anja Hagting, Rhys Grant, Maria De Luca, Italia Anna Asteriti, Giulia Guarguaglini, Alessandro Paiardini, Catherine Lindon
Revisiting degron motifs in human AURKA required for its targeting by APC/C FZR1 . Life science alliance 6 (2) (2022)
Roberta Cacioppo, Catherine Lindon
Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A. Open biology 12 (9) (2022)
Francesco Davide Naso, Dalila Boi, Camilla Ascanelli, Georgiana Pamfil, Catherine Lindon, Alessandro Paiardini, Giulia Guarguaglini
Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer. Oncogene 40 (23) (2021)
Richard Wang, Camilla Ascanelli, Ahmed Abdelbaki, Alex Fung, Tim Rasmusson, Iacovos N Michaelides, Karen Roberts, Catherine Lindon
Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool. Communications biology 4 (1) (2021)
Dalila Boi, Fani Souvalidou, Davide Capelli, Federica Polverino, Grazia Marini, Roberta Montanari, Giorgio Pochetti, Angela Tramonti, Roberto Contestabile, Daniela Trisciuoglio, Patrizia Carpinelli, Camilla Ascanelli, Catherine Lindon, Alessandro De Leo, Alessandro Tossi, Roberto Di Santo, Roberta Costi, Giulia Guarguaglini, Alessandro Paiardini
PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc. International journal of molecular sciences 22 (23) (2021)
Ahmed Abdelbaki, H Begum Akman, Marion Poteau, Rhys Grant, Olivier Gavet, Giulia Guarguaglini, Catherine Lindon
AURKA destruction is decoupled from its activity at mitotic exit but is essential to suppress interphase activity. Journal of cell science 133 (12) (2020)
Rhys Grant, Ahmed Abdelbaki, Alessia Bertoldi, Maria P Gavilan, Jörg Mansfeld, David M Glover, Catherine Lindon
Constitutive regulation of mitochondrial morphology by Aurora A kinase depends on a predicted cryptic targeting sequence at the N-terminus. Open biology 8 (6) (2019)

Catherine Lindon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Catherine Lindon